Becton, Dickinson and Co. | Ativos



Assets Alterar Data
Abbott USD 81.41B 7.06B 2024-12
Agilent USD 11.91B 68M 2025-01
Align Technology USD 6.21B 151.37M 2024-12
Avanos Medical USD 1.15B 502M 2024-12
Baxter International USD 25.78B 894M 2024-12
Becton, Dickinson and Co. USD 54.67B 2.62B 2024-12
Bio-Rad Laboratories USD 9.36B 1.24B 2024-12
Boston Scientific USD 39.4B 1.32B 2024-12
Cooper Companies USD 12.22B 93M 2025-01
Danaher USD 77.54B 3.07B 2024-12
Dentsply International USD 5.75B 873M 2024-12
Dexcom USD 6.48B 130.7M 2024-12
Edwards Lifesciences USD 13.06B 84.1M 2024-12
Exact Sciences USD 5.93B 820.43M 2024-12
Globus Medical USD 5.25B 165.71M 2024-12
Hologic USD 8.73B 427.3M 2024-12
Insulet USD 3.09B 62.3M 2024-12
Integra LifeSciences USD 4.04B 28.38M 2024-12
Intuitive Surgical USD 18.74B 999.8M 2024-12
J&J USD 180.1B 1.82B 2024-12
Masimo USD 2.63B 462.1M 2024-12
Medtronic USD 89.97B 69M 2025-01
Patterson Companies USD 2.83B 13.02M 2025-01
Solventum Corp 14.46B 288M 2024-12
Stryker USD 42.97B 862M 2024-12
Tandem Diabetes Care USD 967.66M 9.93M 2024-12
Teleflex USD 7.1B 388.38M 2024-12
Terumo JPY 1.88T 125.37B 2024-12
Thermo Fisher Scientific USD 97.32B 3.04B 2024-12
Zimmer Biomet Holdings USD 21.37B 355M 2024-12



Becton, Dickinson and Co. Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.